TherapeuticsmdTXMD
13F holders, Q1 2026 (March 31)At the end of Q1 2026, 49 institutions reported holding Therapeuticsmd Inc. (TXMD) in their 13F filings, up 5 from Q4 2025. 7 opened new positions and 3 sold out. The largest holders were Rubric Capital Management LP ($2.4M), Clearline Capital LP ($1.3M) and Squadron Capital Management LLC ($849K). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Therapeuticsmd Inc.
- CUSIP
- 88338N206
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 7 | $944K |
| Exits | 3 | $180 |
All 13F filers, Q4 2025 → Q1 2026: 561,308 shares bought and 41,118 shares sold, net +520,190 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 49 holders
| Rubric Capital Management LP | 0.03% | No change | 1,192,191 | $2.4M |
| Clearline Capital LP | 0.10% | No change | 635,222 | $1.3M |
| Squadron Capital Management LLC | 0.34% | New | 420,421 | $849K |
| Vanguard Capital Management LLC | 0.00% | — | 353,697 | $714K |
| Tejara Capital Ltd | 0.23% | Reduce -1.4% | 345,852 | $699K |
| ADAR1 Capital Management, LLC | 0.03% | No change | 209,210 | $423K |
| Renaissance Technologies | 0.00% | Add +51.5% | 146,200 | $295K |
| Morgan Stanley | 0.00% | No change | 129,217 | $261K |
| BlackRock, Inc. | 0.00% | Reduce -0.8% | 115,145 | $233K |
| Geode Capital Management, LLC | 0.00% | Add +3.5% | 109,817 | $222K |
| Citadel Advisors | 0.00% | Add +141.9% | 68,314 | $138K |
| Vanguard Fiduciary Trust Co. | 0.00% | — | 63,831 | $129K |
| State Street Corp. | 0.00% | No change | 30,100 | $61K |
| XTX Topco Ltd | 0.00% | New | 27,487 | $56K |
| Susquehanna International Group, LLP | 0.00% | Reduce -39.6% | 21,220 | $43K |
| Bridgeway Capital Management, LLC | 0.00% | No change | 17,000 | $34K |
| Northern Trust Corp. | 0.00% | Reduce -2.2% | 16,093 | $33K |
| Dimensional Fund Advisors LP | 0.00% | New | 10,706 | $22K |
| Cygnus Capital Advisors, LLC | 0.01% | New | 9,069 | $18K |
| Vanguard Global Advisers, LLC | 0.00% | — | 4,937 | $10K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -38.9% | 1,509 | $3K |
| National Bank of Canada | 0.00% | No change | 610 | $1K |
| Smartleaf Asset Management LLC | 0.00% | No change | 601 | $1K |
| UBS Group AG | 0.00% | Reduce -70.3% | 331 | $669 |
| JPMorgan Chase & Co. | 0.00% | No change | 293 | $583 |
| SBI Securities Co., Ltd. | 0.00% | Add +4.7% | 267 | $539 |
| US Bancorp \de | 0.00% | No change | 246 | $497 |
| BNP Paribas Financial Markets | 0.00% | No change | 226 | $457 |
| Osaic Holdings, Inc. | 0.00% | Reduce -98.3% | 153 | $308 |
| Huntington National Bank | 0.00% | No change | 120 | $242 |
| Wells Fargo & Company | 0.00% | Add +210.8% | 115 | $232 |
| FMR LLC | 0.00% | Reduce -99.4% | 51 | $103 |
| Activest Wealth Management | 0.00% | No change | 40 | $81 |
| Steward Partners Investment Advisory, LLC | 0.00% | No change | 35 | $71 |
| Farther Finance Advisors, LLC | 0.00% | Add +3.3% | 31 | $62 |
| IFP Advisors, Inc | 0.00% | No change | 21 | $42 |
| Cwm, LLC | 0.00% | No change | 20 | $40 |
| Provenance Wealth Advisors, LLC | 0.00% | No change | 20 | $40 |
| Truvestments Capital LLC | 0.00% | No change | 10 | $20 |
| Harbour Investments, Inc. | 0.00% | No change | 8 | $16 |
| Assetmark, Inc. | 0.00% | No change | 4 | $8 |
| Advisory Services Network, LLC | 0.00% | New | 4 | $8 |
| Group One Trading LLC | 0.00% | Reduce -99.9% | 2 | $4 |
| Bogart Wealth, LLC | 0.00% | New | 2 | $4 |
| Smallwood Wealth Investment Management, LLC | 0.00% | No change | 2 | $4 |
| Johnson Financial Group, Inc. | 0.00% | New | 1 | $3 |
| EverSource Wealth Advisors, LLC | 0.00% | No change | 1 | $2 |
| Royal Bank of Canada | 0.00% | Add +23.4% | 190 | $0 |
| Banque Cantonale Vaudoise | 0.00% | No change | 7 | $0 |
"% of holder's portfolio" is TXMD's weight in each manager's 13F, not the share of Therapeuticsmd Inc. the manager owns.